NextCure, Inc.
NXTC—
$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-19.65
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$22.38M
Net income
$-55.84M
Net margin
-249.5%
Gross margin
—
Dividends & financials
NextCure, Inc. (NXTC) reported revenue of $22.38M and net income of $-55.84M, or $-19.65 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
